Seeing Signals, Sensing Risks
Cell therapies, real-time BCI speech, and mental privacy battles.
Real-time speech restoration, Neuralink's BCI expansion, and the silence of regulators.
It's been a quiet week, so let's take some time to reflect on how we could make this newsletter best serve you.
From expressive brain-computer speech and ALS survival gains to Neuralink’s $650M raise and UNESCO’s ethics vote—this week reshapes neurotechnology’s future.
Cognixion and Blackrock Neurotech expand global access to a wearable brain-computer interface that blends EEG, AR, and neurofeedback into one research-ready device.
Paradromics hits a milestone with human neural recording, AI transforms diagnostics, and new pathways emerge for preventing Alzheimer’s and detecting dementia early.
BCIs, Ethics & Engineered Minds: From Thought-Control to Genetic Targeting
BCIs Go Global, Ethics Go Critical & Implants Go Smart
Minds Over Machines: Apple, Synchron, and the Rise of Brain-Driven Tech
From Thought to Action: Advances in Brain Interfaces, Neural Mapping, and Non-Invasive Therapies
Minds Connected: Ethics, Implants, and the Expanding Frontier of Neurotech
